Hepatitis C in Drug and Alcohol Settings Education Program
- : Online
The Hepatitis C in Drug and Alcohol Settings Education Program is delivered in three parts:
- Part 1 consists of an eLearning component introducing the learner to topics related to the assessment, management and treatment of hepatitis C.
- Part 2 consists of a highly interactive face-to-face workshop building on the knowledge and skills gained in Part 1 by enabling practical and collaborative application of concepts and theory through case discussions and simulation-based models facilitated by experts in the field.
- Part 3 consists of a tailored capacity strengthening toolkit including: a checklist for the assessment and treatment of HCV in drug and alcohol settings; local referral pathways; FibroScan® access forms; an assessment pro forma; and quick reference guides.
Total lecture hours:
Personal study hours:
Total contact hours:
The online modules provide background information on HCV epidemiology, disease progression, screening and diagnosis of HCV, assessment of liver disease severity and co-factors for disease progression, patient assessment, treatment and monitoring. The modules provide learners with a robust, application-focused learning experience. The modules are interactive and include case-based questions requiring exploration of provided resources in order to gauge participants’ understanding.
Case Study. The capacity strengthening toolkit is intended to provide practical tools to implement HCV testing and treatment processes. The toolkit will be tailored in-line with local referral pathways and Fibroscan® access methods at each location. Some resources will be applicable only for the local area of workshop delivery, many, such as DAA treatment regimen quick reference guides, management procedure templates and assessment checklists, will be relevant regardless of practice location.
- Describe the risk factors for HCV infection enabling effective practice screening processes and prevention education
- Demonstrate competence interpreting clinical and other relevant information to provide effective care of people living with HCV infection
- Demonstrate competence in liver disease assessment
- Demonstrate understanding of DAA therapy for the treatment of HCV and competence in selecting and prescribing appropriate therapy
- Monitor patients on treatment and posttreatment appropriately